Tăng sinh nội mạc sau khi phẫu thuật cắt bỏ mảng xơ với thiết bị Silverhawk so với nong mạch qua da (PTA) trong các trường hợp tái tắc mạch huyết khối ở đoạn động mạch đùi - khoeo: Một thử nghiệm pilốt có kiểm soát, ngẫu nhiên

Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG et al (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33(Suppl 1):S1–S75 Tendera M, Aboyans V, Bartelnik ML, Baumgartner I, Clement D, Collet JP et al (2011) ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. The task force on the diagnosis and treatment of peripheral artery diseases of the European society of cardiology (ESC). Eur Heart J 32(22):2851–2906 Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cenja M, Lammer J, Minar E (2007) Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 115:2745–2749 Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cenja M, Lammer J, Minar E (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354:1879–1888 Sabeti S, Mlekusch W, Amighi J, Minar E, Schillinger M (2005) Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther 12:6–12 Laird JR, Katzen BT, Scheinert D et al (2010) Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 3:267–276 Wissgott C, Kamusella P, Andresen R (2011) Behandlung von Instent-Reokklusionen der femoropoplitealen Arterien mit einem mechanischem Rotationskatheter. Röfo 183:939–944 Zeller T, Rastan A, Sixt S et al (2006) Long-term results after directional atherectomy of femoropopliteal lesions. J Am Coll Cardiol 48:1573–1578 Yeo KK, Mail U, Laird JR (2011) Outcomes following treatment of femoropopliteal in-stent restenosis: a single-center experience. Catheter Cardiovasc Interv 78:604–608 Tosaka A, Soga Y, Iida O, Ishihara T, Hirano K, Suzuki K et al (2012) Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 59:16–23 Schillinger M, Minar E (2009) Past, present and future of femoropopliteal stenting. J Endovasc Ther 16:1147–1152 Zeller T, Macharzina R, Tepe G (2010) The role of DES in peripheral in-stent restenosis. J Cardiovasc Surg 51:561–565 Dick P, Sabeti S, Mlekusch W et al (2008) Conventional balloon angioplasty versus cutting balloon angioplasty for treatment of femoropopliteal in-stent restenosis: a randomized controlled trial. Radiology 248:297–302 Sillingardi R, Cataldi V, Moratto J et al (2010) Mechanical atherectomy in instent restenosis: preliminary results at the iliac and femoropopliteal arteries with the rotarex System. J Cardiovasc Surg 51:543–550 Scheller B, Speck U, Abramjuk C et al (2004) Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110(7):810–814 Laird JR, Yeo KK (2012) The treatment of femoropopliteal in-stent restenosis. JACC 59:24–25 Laird JR, Yeo KK, Rocha-Singh K, Das T, Joye J, Dippel E, Reddy B, Botti C, Jaff MR (2012) Excimer laser with adjunctive balloon angioplasty and the heparin-coated self expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve months results from the salvage study. Catheter Cardiovasc Interv (Epub ahead of print) Soga Y, Iida O, Hirano K, Suzuki K, Yokoi H, Nobuyoshi M (2012) Restenosis after stent implantation for superficial femoral artery disease in patients treated with cilostazol. Catheter Cardiovasc Interv 79:541–548 Shrikhande G, McKinsey JF (2008) Use and abuse of atherectomy: where should it be used? Semin Vasc Surg 21:204–209 Garcia LA, Lyden SP (2009) Atherectomy for infrainguinal peripheral artery disease. J Endovasc Ther 16(Suppl II):105–115 Speck U, Scheller B, Abramjuk C et al (2006) Neointima inhibition: comparison of effectiveness of nonstent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology 240:411–418 Cremers B, Biedermann M, Mahnkopf D et al (2009) Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model. Clin Res Cardiol 98:325–330 Cremers B, Speck U, Kaufels N et al (2009) Drug-eluting balloon: very short-term exposure and overlapping. Thromb Haemost 101:201–206 Rowinsky EK, Donehower RC (1995) Paclitaxel (Taxol). N Engl J Med 332:1004–1014 Margolis J, McDonald J, Heuser R, Klinke P, Waksman R, Virmani R, Desai N, Hilton D (2007) Systemic nanoparticle paclitaxel (nab-Paclitaxel) for in-stent restenosis I (SNAPIST-I): a first in-human safety and dose-finding study. Clin Cardiol 30:165–170